• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在荷兰,精确且准确地衡量缺勤情况作为计算生产率成本的基础。

Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands.

作者信息

Severens J L, Mulder J, Laheij R J, Verbeek A L

机构信息

Department of Medical Technology Assessment, University of Nijmegen, The Netherlands.

出版信息

Soc Sci Med. 2000 Jul;51(2):243-9. doi: 10.1016/s0277-9536(99)00452-9.

DOI:10.1016/s0277-9536(99)00452-9
PMID:10832571
Abstract

The impact of disease on the ability of a person to perform work should be part of an economic evaluation when a societal viewpoint is used for the analysis. This impact is reflected by calculating productivity costs. Measurement of these costs is often performed retrospectively. The purpose of our study was to study precision and accuracy of a retrospective self-administered questionnaire on sick leave. Employees of a company were asked to indicate the number of days absent from work due to illness during the past 2 weeks, 4 weeks, 2 months, 6 months, and the past 12 months. The percentage of respondents with an absolute difference of a maximum of respectively 0, 1, 2, 3, 4, 5, 6, 7, 8, and 9 or more days between reported, and company-registered absence due to illness was determined. Besides this, the proportional difference was calculated. A systematic difference was tested with a signed rank test. Of the reported data, 95% matched the registered data perfectly when the recall period was limited to 2 and 4 weeks. This percentage decreased to 87%, 57%, and 51% for 2 months, 6 months, and 12 months. The weighted mean proportional differences for the recall periods were respectively 32.9, 35.2, 45.3, 34.9, and 113.6%. No systematic positive or negative difference was found between registered and reported sick leave. The results suggest that the recall period for retrospective measurement of sick leave is limited according to the precision level, which seems to be appropriate for the subject and the purpose of the study. We recommend using a recall period of no more than 2 months.

摘要

当从社会视角进行分析时,疾病对个人工作能力的影响应作为经济评估的一部分。这种影响通过计算生产力成本来体现。这些成本的测量通常是回顾性的。我们研究的目的是探讨一份关于病假的回顾性自填问卷的准确性和精确性。一家公司的员工被要求指出在过去2周、4周、2个月、6个月以及过去12个月中因病缺勤的天数。确定了报告的因病缺勤天数与公司记录的因病缺勤天数之间绝对差值最多分别为0、1、2、3、4、5、6、7、8和9天及以上的受访者百分比。除此之外,还计算了比例差异。使用符号秩检验来检验系统差异。当回顾期限制在2周和4周时,报告数据中有95%与记录数据完全匹配。对于2个月、6个月和12个月,这一百分比分别降至87%、57%和51%。各回顾期的加权平均比例差异分别为32.9%、35.2%、45.3%、34.9%和113.6%。在记录的病假和报告的病假之间未发现系统性的正差异或负差异。结果表明,根据精确程度,病假回顾性测量的回顾期是有限的,这似乎适合该研究的主题和目的。我们建议使用不超过2个月的回顾期。

相似文献

1
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The Netherlands.在荷兰,精确且准确地衡量缺勤情况作为计算生产率成本的基础。
Soc Sci Med. 2000 Jul;51(2):243-9. doi: 10.1016/s0277-9536(99)00452-9.
2
Cost-utility analysis of a one-time supervisor telephone contact at 6-weeks post-partum to prevent extended sick leave following maternity leave in The Netherlands: results of an economic evaluation alongside a randomized controlled trial.荷兰一项产后 6 周时一次性主管电话随访以预防产假后延长病假的成本效用分析:一项经济评价与随机对照试验的结果。
BMC Public Health. 2011 Jan 27;11:57. doi: 10.1186/1471-2458-11-57.
3
Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost.强直性脊柱炎对病假、出勤和无报酬生产力的影响,以及对社会成本的估算。
Ann Rheum Dis. 2010 Jun;69(6):1123-8. doi: 10.1136/ard.2009.116764. Epub 2010 May 3.
4
Indirect costs associated with metastatic breast cancer.转移性乳腺癌相关的间接成本。
J Med Econ. 2013 Oct;16(10):1169-78. doi: 10.3111/13696998.2013.826228. Epub 2013 Aug 19.
5
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.强直性脊柱炎导致的工作状态及生产力成本:三个欧洲国家的比较
Ann Rheum Dis. 2002 May;61(5):429-37. doi: 10.1136/ard.61.5.429.
6
Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.类风湿关节炎(RA)患者的间接成本评估:健康经济患者问卷HEQ-RA数据与保险理赔数据的比较
Arthritis Rheum. 2005 Apr 15;53(2):234-40. doi: 10.1002/art.21080.
7
Cost-effectiveness and cost-benefit analyses of a multidisciplinary intervention compared with a brief intervention to facilitate return to work in sick-listed patients with low back pain.多学科干预与简短干预促进低背痛休病假患者重返工作的成本效益和成本效益分析。
Spine (Phila Pa 1976). 2013 Jun 1;38(13):1059-67. doi: 10.1097/BRS.0b013e31828ca0af.
8
[Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].[德国类风湿关节炎的生产力成本。成本构成及主要成本组成部分的预测]
Z Rheumatol. 2006 Oct;65(6):527-34. doi: 10.1007/s00393-005-0024-1.
9
Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals.心血管合并症对风湿性疾病患者工作参与的影响:一项针对在职人群的前瞻性队列研究。
Arthritis Care Res (Hoboken). 2014 Jan;66(1):157-63. doi: 10.1002/acr.22095.
10
Cost-effectiveness of 40-hour versus 100-hour vocational rehabilitation on work participation for workers on sick leave due to subacute or chronic musculoskeletal pain: study protocol for a randomized controlled trial.针对因亚急性或慢性肌肉骨骼疼痛而休病假的工人,40小时与100小时职业康复对工作参与度的成本效益:一项随机对照试验的研究方案
Trials. 2015 Jul 28;16:317. doi: 10.1186/s13063-015-0861-4.

引用本文的文献

1
Trends in work participation among patients with inflammatory rheumatic musculoskeletal diseases (iRMDs): Data from the German National Database (2010-2022).炎症性风湿性肌肉骨骼疾病(iRMDs)患者的工作参与趋势:来自德国国家数据库(2010 - 2022年)的数据。
RMD Open. 2025 Jan 25;11(1):e004980. doi: 10.1136/rmdopen-2024-004980.
2
Occupational support following arthroplasty of the lower limb (OPAL): trial protocol for a UK-wide phase III randomised controlled trial.下肢关节置换术后的职业支持(OPAL):一项全英国范围的III期随机对照试验的试验方案
BMJ Open. 2024 Sep 16;14(9):e085962. doi: 10.1136/bmjopen-2024-085962.
3
Using intervention mapping to facilitate and sustain return-to work after breast cancer: protocol for the FASTRACS multicentre randomized controlled trial.
使用干预映射促进和维持乳腺癌后的重返工作:FASTRACS 多中心随机对照试验方案。
BMC Cancer. 2024 Sep 5;24(1):1107. doi: 10.1186/s12885-024-12796-4.
4
Cost of illness of patients with small fiber neuropathy in the Netherlands.荷兰小纤维神经病患者的疾病经济负担。
Pain. 2024 Jan 1;165(1):153-163. doi: 10.1097/j.pain.0000000000003008. Epub 2023 Aug 4.
5
Platelet-Rich Plasma Injections for the Treatment of Ankle Osteoarthritis.富血小板血浆注射治疗踝关节骨关节炎。
Am J Sports Med. 2023 Aug;51(10):2625-2634. doi: 10.1177/03635465231182438. Epub 2023 Jul 7.
6
Economic and health impacts of the Change4Life Food Scanner app: Findings from a randomized pilot and feasibility study.“改变生活”食物扫描仪应用程序的经济和健康影响:随机试点及可行性研究结果
Front Nutr. 2023 Mar 16;10:1125542. doi: 10.3389/fnut.2023.1125542. eCollection 2023.
7
Development of an Instrument for the Assessment of Health-Related Multi-sectoral Resource Use in Europe: The PECUNIA RUM.开发一种用于评估欧洲与健康相关的多部门资源利用的工具:PECUNIA RUM。
Appl Health Econ Health Policy. 2023 Mar;21(2):155-166. doi: 10.1007/s40258-022-00780-7. Epub 2023 Jan 9.
8
Do Differences in Drinking Attitudes and Alcohol-Related Problems Explain Differences in Sick Leave? A Multilevel Analysis of 95 Work Units Within 14 Companies From the WIRUS Study.饮酒态度和与酒精相关问题的差异是否可以解释病假的差异?来自 WIRUS 研究的 14 家公司的 95 个工作单位的多层次分析。
Front Public Health. 2022 May 31;10:817726. doi: 10.3389/fpubh.2022.817726. eCollection 2022.
9
Cost and cost-effectiveness of the 'Stand and Move at Work' multicomponent intervention to reduce workplace sedentary time and cardiometabolic risk.“站立和运动工作”多组分干预措施降低工作场所久坐时间和心血管代谢风险的成本和成本效益。
Scand J Work Environ Health. 2022 Jul 1;48(5):399-409. doi: 10.5271/sjweh.4022. Epub 2022 Mar 25.
10
Internet-delivered cognitive behavioral therapy (iCBT) for common mental disorders and subsequent sickness absence: a systematic review and meta-analysis.互联网提供的针对常见精神障碍的认知行为疗法(iCBT)及随后的病假情况:一项系统评价和荟萃分析。
Scand J Public Health. 2023 Feb;51(1):137-147. doi: 10.1177/14034948221075016. Epub 2022 Feb 4.